Electronic systems can help health professionals find information quickly. Examples could be looking up the safety of analgesics for use during pregnancy, as discussed by Debra Kennedy, or the efficacy of nonsurgical treatments for skin cancer, as reviewed by Stephen Shumack. However, James Reeve and Michelle Sweidan inform us that there are no standards for electronic prescribing systems.
In Australia, electronic prescribing (e-prescribing) systems in general practice were first developed in the early 1990s by a few innovative general practitioners who wrote software for their own use. The uptake of e-prescribing systems was accelerated in 1999 because of Commonwealth government incentive payments of $10 000 to practices that acquired an email address and used e-prescribing software to write the majority of their prescriptions. Currently over 90% of general practitioners use one of the 20 or so commercial systems that are available to write prescriptions, order pathology and other tests, record medical progress notes or communicate with other healthcare providers. 1 Despite the widespread use of e-prescribing systems, there are no clear standards or guidelines for their development. This has led to a variety of systems with markedly different capabilities, particularly in terms of assisting general practitioners to prescribe safely and effectively.
overseas studies have shown that e-prescribing systems can enhance the safety and quality of prescribing by ensuring complete and legible prescription orders, improving the detection of drug allergies and by reducing medication errors and adverse reactions. [2] [3] [4] [5] However, these systems can also have unfavourable effects on workflow and communications, and can have unintended effects on prescribing. For example, they may introduce new types of errors [6] [7] [8] and high levels of unhelpful alerts, and impact on repeat prescribing. 9 General practitioners have also expressed concern about the comprehensiveness and accuracy of some of the information provided in their software. 10 In a comparative study of nine electronic prescribing and dispensing systems used in primary care in Australia in 2006, an expert panel found that most systems do not offer consistently useful and relevant information for general practitioners and pharmacists to make decisions about drug interactions. 11 Recently, a number of organisations and researchers have identified desirable functionality and safety features for e-prescribing systems in various healthcare settings. [12] [13] [14] [15] [16] In Australia, the National Prescribing Service (NPS) has worked with general practitioners, professional organisations and the Medical Software Industry Association to identify the key features of e-prescribing systems which support patient safety and quality care. 17 Many of the safety and quality features identified for general practice apply equally to other settings such as hospitals or aged care.
For safety and quality, an ideal system needs suitable information resources, interoperability with other systems and clinical decision support. The goal of clinical decision support is 'to provide clinicians or patients with clinical knowledge and patient-related information, intelligently filtered and presented at appropriate times, to enhance patient care'. 18 The ideal system should record clinical data such as diagnoses, medicines and allergies in a standard coded format. This helps to facilitate one system being able to 'talk to' another system and easily exchange patient data, for example with hospital systems or personal electronic health records when they become available. Information about recommended therapeutic options for the current diagnosis should be offered. The system ought to ensure that medicine selection processes are safe. In addition to drug interaction alerts, the system should provide warnings if a drug is contraindicated, the dosage regimen is potentially harmful, or if the drug is the subject of new safety advice from the Therapeutic Goods Administration. Warnings www.australianprescriber.com [14] [15] [16] 19 and USA 18 on desirable functionality and design of systems to optimise usability and patient safety -much of this guidance will be applicable to the Australian setting.
Given the widespread use of electronic prescribing systems in day-to-day practice, coordinated activity to ensure these systems meet key quality and safety criteria is overdue. Clear guidance and standards are a prerequisite. Government, professional bodies and the software industry have a shared responsibility to develop and support processes to improve quality and safety in e-prescribing systems in Australia. The hope is certainly that use of a polypill formulation will improve adherence and reduce costs. The analgesic efficacy of codeine resides predominantly in the morphine metabolite. Codeine-6-glucuronide is reported to have the low efficacy of the parent compound. 1 Low efficacy of codeine in those with low activity of CYP2D6 (poor metabolisers) is recognised. In addition, of concern is
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